The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study

Pier Luigi ZinzaniInstitute of Hematology “Seràgnoli,” University of Bologna, Bologna, Italy; Correspondence[email protected]

Luigi RigacciDepartment of Haematology, “Careggi” Hospital, Firenze, Italy;

Maria Cristina CoxHaematology Unit, AO Sant'Andrea, Department of Clinical and Experimental Medicine, La Sapienza University, Rome, Italy;

Liliana DevizziDivision of Hematology, National Cancer Institute, Milan, Italy;

Alberto FabbriDivision of Haematology, “S. Maria alle Scotte” Hospital, Siena, Italy;

Francesco ZajaDepartment ofHaematology, DISM, AOUD S. M. Misericordia, Udine, Italy;

Alice Di RoccoDepartment of Cellular Biotechnologies and Haematology, “Sapienza” University, Rome, Italy;

Giuseppe RossiDepartment of Haematology, Spedali Civili, Brescia, Italy;

Sergio StortiCentre for High Technology Research and Education in Biomedical Sciences, University “Cattolica del Sacro Cuore,”Campobasso, Italy;

Pier Paolo FattoriIstituto Scientifico Romagnolo per lo studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy;

Lisa ArgnaniInstitute of Hematology “Seràgnoli,” University of Bologna, Bologna, Italy;

Umberto VitoloAO Città della Salute e della Scienza di Torino, Torino, Italy

Potential conflict of interest